Literature DB >> 24451881

Paranasal bone: the prime factor affecting the decision to use transsinus vs zygomatic implants for biomechanical support for immediate function in maxillary dental implant reconstruction.

Ole T Jensen, Mark W Adams, Edmund Smith.   

Abstract

Paranasal bone affects the decision-making process for placement of implants for immediate function in the highly resorbed maxilla. The most important bone for apical fixation of implants in this setting is the lateral nasal bone mass. Maximum available bone mass found at the pyriform above the nasal fossa, designated M point, can most often engage two implants placed at 30-degree angles. The second most important area of paranasal bone mass is the subnasal bone of the premaxilla, which is required to engage an angled implant at the alveolar crest. However, only 4 to 5 mm in height is needed when implants are angled posterior to engage M point. The third most important paranasal bone site for implant fixation is the midline nasal crest extending upward to the vomer. This site, which is usually type 1/2 bone, can engage implants apically and provide enough fixation for immediate function even if implants are short. These anatomical bone sites enable placement of implants to obtain a 12- to 15-mm anterior-posterior spread, which is favorable for immediate function.

Entities:  

Mesh:

Year:  2014        PMID: 24451881     DOI: 10.11607/jomi.te52

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Implants        ISSN: 0882-2786            Impact factor:   2.804


  2 in total

1.  Stresses generated by two zygomatic implant placement techniques associated with conventional inclined anterior implants.

Authors:  Paulo H T Almeida; Sergio H Cacciacane; Fabiana M G França
Journal:  Ann Med Surg (Lond)       Date:  2018-04-21

2.  Extra-long transnasal implants as alternative for Quad Zygoma: Case report.

Authors:  Paulo H T Almeida; Sergio H Cacciacane; Ayrton Arcazas Junior
Journal:  Ann Med Surg (Lond)       Date:  2021-07-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.